Several reports have suggested that particulate matter (PM) exposure increases the risk for atrial arrhythmias. However, data from large-scale epidemiologic studies supporting this hypothesis are lacking. We examined the association of PM o 2.5 μm in diameter (PM 2.5 ) concentration with premature atrial contractions (PACs) in 26,609 (mean age = 65 ± 9.4 years; 55% female; 41% black) participants from the REGARDS (REasons for Geographic And Racial Differences in Stroke) study. Estimates of short-(2 weeks) and long-term (1 year) PM 2.5 exposure were computed before each participant's baseline visit using geographic information system data on the individual level at the coordinates of study participants' residences. PACs were identified from baseline electrocardiograms. A total of 2140 (8.2%) participants had evidence of PACs on the baseline electrocardiogram. Short-term PM 2.5 (per 10 μg/m 3 ) exposure was not associated with PACs (OR = 1.09, 95% CI = 0.98, 1.23). Increases in long-term PM 2.5 (per 10 μg/m 3 ) were associated with PACs (OR = 1.40, 95% CI = 1.10, 1.78). Interactions were not detected for short-and long-term PM 2.5 exposure by age, sex, or race. Long-but not short-term PM 2.5 exposure is associated with PACs. This suggests a role for long-term PM 2.5 exposure in initiating supraventricular arrhythmias that are triggered by PACs.
INTRODUCTION
Several reports have suggested that particulate matter (PM) exposure increases the risk for the development of arrhythmias. This is supported by data that have linked short-term (24-h) PM exposure with an increased risk for ventricular arrhythmias (ventricular tachycardia and ventricular fibrillation) in patients with implantable cardioverter-defibrillators (ICDs), 1, 2 and among individuals with coronary heart disease. 3 In addition, a number of studies have suggested that air pollution is associated with the development of atrial arrhythmias. Two studies among patients with ICDs have shown that increases in ozone and PM 2.5 (PM o2.5 μm in diameter) concentrations are associated with atrial fibrillation events. 4, 5 Other reports have linked short-term PM 2.5 exposure with premature atrial contractions (PACs). 3, 6, 7 Data from large-scale epidemiologic studies to support an association between PM exposure and atrial arrhythmias are lacking. The findings of the aforementioned studies are limited in generalizability as they were conducted in specific patient populations (e.g., patients with ICDs) with small sample sizes. Furthermore, the impact of long-term PM exposure on the risk of atrial arrhythmias has not been explored. Therefore, the purpose of this study was to examine the associations of short-and longterm PM 2.5 exposure with non-sustained atrial rhythm disorders (PACs) in the REGARDS (REasons for Geographic And Racial Differences in Stroke) study.
PATIENTS AND METHODS

Study Population and Design
Details of REGARDS have been published previously. 8 Briefly, REGARDS is a prospective cohort study designed to identify causes of regional and racial disparities in stroke mortality. The study sampled blacks and individuals residing in the stroke belt (North Carolina, South Carolina, Georgia, Alabama, Mississippi, Tennessee, Arkansas, and Louisiana) between January 2003 and October 2007. This included participants from the stroke buckle (coastal plains of North Carolina, South Carolina, and Georgia), as this region experiences a stroke mortality rate considerably higher than the rest of the United States. 9 A total of 30,239 participants were recruited from a commercially available list of residents using postal mailings and telephone data. Demographic information and medical histories were obtained using a computer-assisted telephone interview (CATI) system that was conducted by trained interviewers. In addition, a brief in-home physical examination was performed 3 to 4 weeks after the telephone interview. During the in-home visit, trained staff collected information regarding medications, blood and urine samples, and a resting 1 electrocardiogram. All participants provided written informed consent and the study was approved by all participating institutional review boards.
For the purpose of this analysis, participants were excluded if they were missing PM 2.5 exposure or baseline covariate data. In addition, participants who had evidence of pacemakers or sustained atrial rhythm disorders (e.g., atrial fibrillation) were excluded. Estimates were spatially linked with REGARDS participants using geographic information system (GIS) data on the individual level at the geographic coordinates of study participants' residences. Short-term PM 2.5 exposure was computed as the 2-week average value before the baseline visit and longterm exposure was computed as the 1-year average value before the baseline visit. Details of the methods used to compute PM 2.5 exposure and linkage with REGARDS participants have been previously reported. 10 Data from the NASA product of the North American Land Data Assimilation System Phase 2 (NLDAS-2) forcing data set were used to determine 2-week and 1-year temperature averages before the baseline visit. This NLDAS-2 product is based on model reanalysis data, as well as remotely sensed and ground observations, and consists of a grid surface with~14 km resolution over North America.
11
Premature Atrial Contractions Electrocardiograms of study participants were read centrally at the Epidemiological Cardiology Research Center (EPICARE) located at the Wake Forest School of Medicine (Winston-Salem, NC, USA). PACs were ascertained from baseline electrocardiograms using Minnesota code criteria (Minnesota codes 8.1.1 and 8.1.3). 12 Covariates Age, sex, race, income, education, and smoking status were self-reported. Education was categorized into "high school or less" or "some college or more." Smoking was defined as self-reported current cigarette use. Exercise was classified as none or X 1 times per week. Fasting blood samples were obtained and assayed for high-density lipoprotein cholesterol, total cholesterol, and serum glucose. Diabetes was defined as a fasting glucose level X 126 mg/dl (or a non-fasting glucose X 200 mg/dl among those failing to fast) or by self-reported diabetes medication use. The current use of aspirin, antihypertensive medications, and lipid-lowering therapies was self-reported. After the participant rested for 5 min in a seated position, blood pressure was measured using a sphygmomanometer. Two values were obtained following a standardized protocol and averaged. Body mass index was computed as the weight in kg divided by the square of the height in meters. Using baseline electrocardiogram data, left ventricular hypertrophy was defined by the Sokolow-Lyon Criteria. 13 Coronary heart disease was ascertained by self-reported history of myocardial infarction, coronary artery bypass grafting, coronary angioplasty, or stenting, or if evidence of prior myocardial infarction was present on the baseline electrocardiogram. Prior stroke was ascertained by participant selfreported history. Cardiovascular disease was defined as the composite of coronary heart disease and stroke.
Statistical Analyses
Baseline characteristics were examined by the presence of PACs. Categorical variables were reported as frequency and percentage whereas continuous variables were reported as mean ± SD. Statistical significance for categorical variables was tested using the χ 2 method and Student's ttest procedure for continuous variables. Logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs) for the associations of short-and long-term PM 2.5 exposure with PACs, separately. The association was examined per 10 μg/m 3 increase in PM 2.5 concentration. Multivariable models were adjusted as follows: model 1 adjusted for age, sex, race, education, income, geographic region, and average temperature (2-week average for short-term and 1-year average for long-term); model 2 included model 1 covariates, with the addition of known PAC risk factors (current smoking, height, physical inactivity, high-density lipoprotein cholesterol, and cardiovascular disease).
14 In addition, subgroup analyses were performed to evaluate effect modification by age (o 65 years vs ≥ 65 years), sex, and race (black vs white) using a stratification technique and comparing interaction terms in model 2. A sensitivity analysis was also performed in which the association between short-term PM 2.5 exposure and PACs was examined using the average 24 h PM 2.5 concentration before the baseline visit. Statistical significance for all comparisons including interactions was defined as Po0.05. SAS version 9.4 (Cary, NC, USA) was used for all analyses. Statistical significance for categorical variables tested using the χ 2 method, whereas for continuous variables Student's t-test was used.
RESULTS
A total of 26,609 participants (mean age = 65 ± 9.4 years; 55% female; 41% black) were included in this analysis. A total of 2140 (8.2%) participants had evidence of PACs on the baseline electrocardiogram. A higher 1-year average PM 2.5 concentration was observed for those with PACs compared with those without PACs. No difference was observed between the mean 2-week PM 2.5 concentration for those with and without PACs ( Table 1) . Baseline characteristics stratified by the presence of PACs are shown in Table 1 .
Short-term PM 2.5 (per 10 μg/m 3 ) exposure was not associated with PACs (Table 2) . The results were similar when we used the mean 24 h PM 2.5 concentration to define short-term exposure (OR = 1.04, 95% CI = 0.98, 1.11). In contrast, increases in long-term PM 2.5 concentration (per 10 μg/m 3 ) were associated with PACs (Table 3) . No interactions were detected in the short-term (Table 2) and long-term (Table 3) analyses when stratified by age, sex, or race.
DISCUSSION
In this analysis from REGARDS, a large-scale epidemiologic study, short-term PM 2.5 exposure was not associated with PACs. In contrast, we observed a significant association of long-term PM 2.5 exposure with PACs. The data presented demonstrate that the supraventricular arrhythmiogenesis associated with PM 2.5 concentration likely depends on the duration of PM 2.5 exposure.
Several reports have suggested that air pollution triggers the development of atrial arrhythmias. A study of 203 patients with ICDs in Boston (MA, USA) has shown a positive association between episodes of paroxysmal atrial fibrillation and increases in ozone concentration in the hour before the development of the arrhythmia. 4 Similarly, an examination of 176 patients with ICDs in Boston reported that the odds of atrial fibrillation increased by 26% for each 6.0 μg/m 3 increase in PM 2.5 in the 2 h before the event. 5 Other reports have linked short-term PM 2.5 exposure with supraventricular ectopy. An examination of 57 males with coronary heart disease has shown that PM exposure (over 5 days) is associated with runs of supraventricular tachycardia (defined as at least 3 consecutive beats) and a study of 32 non-smoking adults in Steubenville, OH, USA observed a similar association with increases in PM 2.5 exposure over a 10-day period. 3, 6 In addition, a small study of 9 highway patrolmen in North Carolina found an association between 4-day PM 2.5 exposure and supraventricular ectopic beats. 7 In contrast, our data from a large population-based cohort do not support an association between short-term PM 2.5 exposure and PACs. This is consistent with data from the Women's Health Initiative and the Air Pollution and Cardiac Risk and Its Time Course (APACR) study, as these studies did not show an association between short-term PM 2.5 exposure and supraventricular ectopy. 15, 16 Possible explanations for the differences observed with prior reports and the current study include the populations examined, the definition of short-term PM 2.5 exposure, and the methods of short-term PM 2.5 detection. The current study included nearly 26,000 black and white participants and was not limited to individuals with heart disease who had ICDs, a group with an inherent risk for arrhythmia. Short-term exposure was defined using 2-week average PM 2.5 concentrations and a sensitivity analysis was performed using the average 24 h PM 2.5 concentration. It is possible that the relationship between PACs and PM 2.5 varies with different durations to define short-term exposure (e.g., hourly). Similar variation is also possible with long-term PM 2.5 exposure (e.g., 3 and 6 months). Furthermore, PM 2.5 estimates were spatially linked at the geographic coordinates of each participant's residence rather than relying on local monitoring stations.
To our knowledge, there are no studies that have attempted to link long-term PM 2.5 exposure with PACs. Possibly, atrial cardiomyocytes require a longer duration of PM 2.5 exposure before ectopic beats are apparent, as we did not observe an increased risk of PACs with short-term exposure. This would suggest that significant atrial remodeling likely occurs with PM 2.5 exposure and a threshold of cumulative PM 2.5 exists for which the risk of PACs is highest. In addition, it is possible that long-term PM 2.5 exposure decreases the threshold for PACs by altering the autonomic tone of atrial cardiomyocytes. Both mechanisms possibly lead to an increased risk for non-sustained supraventricular arrhythmias. 17 In aggregate, the data presented in this study suggest a potential role for long-term PM 2.5 exposure in initiating supraventricular arrhythmias that are triggered by PACs.
Several reports have linked PM exposure with adverse cardiovascular events, implicating air pollution as a serious public health problem. [18] [19] [20] [21] [22] [23] [24] [25] The data provided in this analysis also implicate prolonged exposure to elevated levels of PM 2.5 as a risk factor for supraventricular ectopic beats. Therefore, it is possible that air pollution is a modifiable risk factor for arrhythmia development and regulations aimed to reduce the level of ambient PM 2.5 concentration should be considered. As we strive for more cost-effective options within our health care system, reductions in air pollution possibly have a role to reduce the burden of atrial arrhythmias, including cost.
The results of the current analysis should be interpreted in the context of certain limitations. Several baseline characteristics (e.g., current smoking) were self-reported and subjected our analysis to recall bias. PACs were detected from a single electrocardiogram recording and participants possibly will be reclassified with subsequent tracings. The PM 2.5 exposure was presumed to be constant during the time periods examined. However, we acknowledge that temporal variation in PM 2.5 concentration was unable to be accounted for as our estimates were measured by satellite. In addition, we linked participants at the level of their home addresses and assumed that each participant spent enough time outdoors to expose them to the level of PM 2.5 measured. PM 2.5 exposure was also estimated on a 10 km grid using EPA ground observation data and MODIS data, and this spatial resolution possibly resulted in inaccurate PM 2.5 estimates. Furthermore, we were unable to determine the components comprising the PM 2.5 exposure and cannot differentiate which PM contributes to our results. Humidity, barometric pressure, and time of day were not collected in our cohort and we were unable to incorporate these covariates into our multivariable models. We also included several risk factors associated with PACs in our multivariable models but cannot exclude the possibility of residual confounding similar to other epidemiologic studies.
In conclusion, the findings of this study suggest that increased levels of long-but not short-term PM 2.5 exposure are associated with PACs. These data implicate a role for long-term PM 2.5 exposure in initiating supraventricular arrhythmias that are triggered by PACs. Further research is needed to confirm our findings and to explore the utility of air pollution reduction to decrease the incidence of supraventricular arrhythmias.
